Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion type Assertion NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_head.
- NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion wasGeneratedBy ECO_0000203 NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_provenance.
- NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion wasDerivedFrom befree-2016 NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_provenance.
- NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion SIO_000772 23771925 NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_provenance.
- NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion evidence source_evidence_literature NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_provenance.
- NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_assertion description "[Compared with the MODY-negative group, MODY-positive participants had lower FCP levels (2.2 ± 1.4 vs 3.2 ± 2.1 ng/mL, P < .01) and fewer type 2 diabetes-like metabolic features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086451.RAddjJ63Tk0oPDut61jXwlYdwZlZD1aTT0lYe7qgrgKgc130_provenance.